PXL/HO/BEC-030/2021-22                                                                          Dt: 15.02.2022

Hyderabad

Dear Sir/Madam,

Subject: Trade Enquiry by Orange & Green Pty Ltd – Australia

Members are kindly aware that Pharmexcil has been facilitating several trade enquiries in close coordination with our missions abroad and promoting Indian pharmaceuticals worldwide. Pharmexcil is further in receipt of communication from High Commission of India, Australia wherein a Australian Pharmaceutical company M/s. Orange & Green Pty Ltd represented by Mr. Rudi van der Vlies, Founder & Executive Director has enquired for suppliers of select pharmaceutical products from India.

It was understood that Mr. Rudi van der Vlies, was one of the Co-Founders and Board Members of Vöost Vitaminhaus, a company started at Orange & Green and later divested into a standalone company before selling it off to Procter & Gamble in April last year. They are currently in the process of starting up another Health & Wellness company in the gut / gastroenterology space, which will be a cooperation with a leading Melbourne Doctor.

https://voostvitamins.com/

https://www.smartcompany.com.au/industries/health/voost-acquired-procter-gamble/

The Australian company is looking to source generic versions (to be packed under their brand) of the following products:

·   Movicol equivalent (macrogol 3350)

·   Gastro-Stop/Imodium equivalent (loperamide 2mg)

·   Buscopan equivalent (hyoscine butyl bromide 10mg)

·   A fibre product (psyllium husk, sterculia, karaya gum or any other non-fermentable fibre)

Member companies interested in this business opportunity may like to contact Mr. Rudi van der Vlies, Founder & Executive Director, M/s. Orange & Green Pty Ltd. Email: rudi.vandervlies@orange-and-green.com, Tel: +61 (0) 438 345 034 (Mobile), +61 (03) 9831 2205 (Office).

With regards

Uday Bhaskar

Director General